Integral Health Asset Management, LLC

Source: SEC Form 13F · as of Mar 2026

Integral Health Asset Management, LLC holds 65 biotech & pharma companies tracked by BioSniper, totaling $1.76B in value as of Mar 2026 (SEC Form 13F).

Companies held

65

Total value held

$1.76B

CompanySharesValue
RVMDREVOLUTION MEDICINES, INC.2,750,000$267.4M
INSMINSMED Inc1,500,000$245.3M
CYTKCYTOKINETICS INC2,600,000$171.4M
REGNREGENERON PHARMACEUTICALS, INC.85,000$65.7M
VERAVera Therapeutics, Inc.1,600,000$64.4M
CAHCardinal Health Inc.270,000$57.1M
ROIVRoivant Sciences Ltd.2,000,000$55.4M
RYTMRHYTHM PHARMACEUTICALS, INC.600,000$52.2M
MRKMerck & Co., Inc.425,000$51.1M
EWTXEdgewise Therapeutics, Inc.1,600,000$50.4M
AZNASTRAZENECA PLC250,000$49.3M
ALHCAlignment Healthcare Inc.2,575,000$45.4M
NVSNovartis AG250,000$38.2M
MLYSMineralys Therapeutics, Inc.1,250,000$33.9M
SRRKScholar Rock Holding Corp500,000$24.6M
ELVElevance Health Inc.75,000$22.0M
BBIOBridgeBio Pharma, Inc.275,000$20.4M
NBIXNEUROCRINE BIOSCIENCES INC150,000$19.8M
ARWRARROWHEAD PHARMACEUTICALS, INC.300,000$18.8M
VRTXVERTEX PHARMACEUTICALS INC / MA40,000$17.9M
ORICOric Pharmaceuticals, Inc.1,400,000$17.7M
ALMSALUMIS INC.800,000$17.6M
QUREuniQure N.V.900,000$14.7M
TARSTarsus Pharmaceuticals, Inc.200,000$14.0M
GILDGILEAD SCIENCES, INC.100,000$13.9M
LLYELI LILLY & Co15,000$13.8M
COGTCogent Biosciences, Inc.350,000$13.5M
ELANElanco Animal Health Inc550,000$13.2M
MDGLMADRIGAL PHARMACEUTICALS, INC.25,000$13.1M
PRAXPraxis Precision Medicines, Inc.40,000$12.9M
DNTHDianthus Therapeutics, Inc. /DE/150,000$12.6M
DGXQuest Diagnostics Incorporated60,000$11.8M
XENEXenon Pharmaceuticals Inc.200,000$11.6M
ERASErasca, Inc.700,000$11.3M
ANROAlto Neuroscience, Inc.500,000$11.2M
BIIBBIOGEN INC.60,000$11.0M
SLNOSOLENO THERAPEUTICS INC325,000$10.9M
IRONDisc Medicine, Inc.170,000$10.9M
NRIXNurix Therapeutics, Inc.700,000$10.8M
LNTHLantheus Holdings, Inc.125,000$9.5M
TNGXTango Therapeutics, Inc.450,000$9.4M
IONSIONIS PHARMACEUTICALS INC125,000$9.4M
BHVNBiohaven Ltd.1,000,000$8.5M
SNDXSyndax Pharmaceuticals Inc350,000$8.2M
VKTXViking Therapeutics, Inc.250,000$8.1M
DFTXDefinium Therapeutics Inc.400,000$7.6M
BEAMBeam Therapeutics Inc.300,000$7.1M
RZLTRezolute, Inc.2,000,000$6.1M
CAPRCAPRICOR THERAPEUTICS, INC.200,000$6.1M
IQVIQVIA Holdings Inc.35,000$6.0M
AXSMAxsome Therapeutics, Inc.35,000$5.9M
PTGXProtagonist Therapeutics, Inc50,000$5.3M
EVMNEvommune, Inc.225,000$5.2M
ACHCAcadia Healthcare Company Inc.200,000$4.7M
ZBHZimmer Biomet Holdings Inc.50,000$4.5M
FBRXForte Biosciences, Inc.150,000$3.9M
LBRXLB PHARMACEUTICALS INC150,000$3.7M
SVRASavara Inc600,000$3.3M
RLMDRELMADA THERAPEUTICS, INC.450,000$3.1M
IMCRImmunocore Holdings plc100,000$3.0M
MAZEMaze Therapeutics, Inc.100,000$3.0M
IKTInhibikase Therapeutics, Inc.1,350,000$2.3M
OLMAOlema Pharmaceuticals, Inc.150,000$2.2M
IVAInventiva S.A.400,000$2.2M
SIONSionna Therapeutics, Inc.50,000$2.0M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Integral Health Asset Management, LLC — Biotech 13F Holdings & Portfolio | BioSniper